EDGAR Filing Documents for 0000898432-09-000087

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

SEC Accession No. 0000898432-09-000087

Filing Date

2009-01-27

Accepted

2009-01-27 16:20:03

Documents

Group Members

BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq	Description	Document	Type	Size
1		targacept.htm	SC 13G/A	261689
	Complete submission text file	0000898432-09-000087.txt		263825

Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611

Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500

BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address 200 EAST FIRST STREET SUITE 300 WINSTON-SALEM NC 27101

Business Address 200 EAST FIRST STREET SUITE 300 WINSTON-SALEM NC 27101 3364802100

TARGACEPT INC (Subject) CIK: 0001124105 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82442 | Film No.: 09548383
SIC: 2834 Pharmaceutical Preparations